Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Alfaro, M.J. (M.J.) | - |
dc.creator | Paramo, J.A. (José Antonio) | - |
dc.creator | Rocha, E. (Eduardo) | - |
dc.date.accessioned | 2012-06-08T18:31:51Z | - |
dc.date.available | 2012-06-08T18:31:51Z | - |
dc.date.issued | 1986 | - |
dc.identifier.citation | Alfaro MJ, Paramo JA, Rocha E. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine. Thromb Haemost 1986 Aug 20;56(1):53-56. | es_ES |
dc.identifier.issn | 0340-6245 | - |
dc.identifier.uri | https://hdl.handle.net/10171/22521 | - |
dc.description.abstract | A prospective study involving 120 consecutive patients undergoing total hip replacement was performed to compare the effectiveness of aspirin (high and low dose) or a combination of heparin plus dihydroergotamine (heparin-DHE) in preventing isotopic and phlebographic deep vein thrombosis (DVT), and to evaluate their effect on postoperative platelet changes. Phlebographic DVT was demonstrated in 9 cases (30%) in control group, in 1 (3.3%) in aspirin (high-dose) group (p less than 0.01), in 1 (3.3%) in aspirin (low-dose) group (p less than 0.01) and in 5 (16.6%) in heparin-DHE group (p = NS). Aspirin was able to reduce the postoperative increase in circulating platelet aggregates, platelet factor 4 and beta-thromboglobulin observed in control group. This study shows that aspirin is effective in the prevention of DVT for patients undergoing total hip replacement. Small aspirin dose (250 mg/day) represents an effective form of prophylaxis in these patients. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Schattauer | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Postoperative deep vein thrombosis | es_ES |
dc.subject | Aspirin | es_ES |
dc.subject | Heparin-dihydroergotamine | es_ES |
dc.title | Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.